Certara stock

Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development..

Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Certara, Inc.'s business for stockholders, potential investors, and financial analysts.Overall, Nice Ltd (ADR) stock has a Value Score of 17, Growth Score of 97 and Quality Score of 94. Certara Inc stock has a Value Score of 14, Growth Score of 50 and Quality Score of 58. Comparing Nice Ltd (ADR) and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.Certara Stock Performance NASDAQ CERT opened at $14.64 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 3.51 and a quick ratio of 3.51.

Did you know?

8 brokerages have issued 1 year price objectives for Certara's stock. Their CERT share price targets range from $16.00 to $24.00. On average, they expect the company's share price to reach $19.71 in the next twelve months. This suggests a possible upside of 31.7% from the stock's current price.Nov 27, 2022 · ClearBridge Investments highlighted stocks like Certara, Inc. (NASDAQ: CERT) in its Q3 2022 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software ... Follow. PRINCETON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in ...

Aug 12, 2022 · Certara became a member of the Nasdaq after an upsized initial public offering of its 29,055,000 shares of Class A common stock at $23 per share. Through the IPO, the company raised $316.3 million ... Nov 7, 2022 · Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares. PRINCETON, N.J.— November 7, 2022 — Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and building transformational healthcare companies, has ... John Gallagher CERT stock SEC Form 4 insiders trading. John has made over 9 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently John exercised 5,746 units of CERT stock worth $437,730 on 27 February 2018.. The largest trade John's ever made was exercising 5,746 units of Certara stock …Sep 13, 2023 · With a price of $14.6 and a GuruFocus Value of $25.18, the stock has a price-to-GF-Value ratio of 0.58. Story continues Despite the insider's recent sell, the undervaluation of Certara Inc's stock ...

According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the …The company showed -9% earnings growth last quarter, while sales growth came in at 15%. Keep an eye out for the company's next round of numbers on or around Mar. 1. The company earns the No. 3 ... ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Certara stock. Possible cause: Not clear certara stock.

4 Apr 2023 ... Certara (CERT), a developer of biosimulation software for drug discovery, dropped Tuesday after Barclays downgraded on valuation concerns.... stock price by the number of shares outstanding. Certara market cap as of December 01, 2023 is $2.34B. Compare CERT With Other Stocks. Sector, Industry, Market ...Sifting through countless of stocks in the Software industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Certara Inc because you’re not sure how they measure up, it’s important to compare them ...

Certara Stock Performance. Certara stock opened at $14.71 on Tuesday. The stock’s 50 day moving average price is $13.73 and its 200 day moving average price is $16.78. The firm has a market capitalization of $2.35 billion, a PE ratio of -70.05, a price-to-earnings-growth ratio of 1.15 and a beta of 1.51. The company has a debt-to-equity ratio ...Certara, Inc. (CERT Quick Quote CERT - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole?

first national bank of nebraska A description of the common stock (the “Common Stock”) of Certara, Inc. (the “Registrant”) will be contained in a prospectus, constituting part of the Registrant’s Registration Statement on Form S-1 (File No. 333-250182) relating to the Common Stock, to be filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended (such prospectus as filed … arrived homewhat is the best financial magazine Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ... trading on phone PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has successfully supported 300 completed submissions to ... best expense tracker app androidbanks with instant virtual debit cardbest home budget spreadsheet Legal Name Certara, Inc. Stock Symbol NASDAQ:CERT. Company Type For Profit. Contact Email [email protected]. Phone Number 415-237-8272. Certara is a pharmaceutical company that accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include … best crypto trading course The estimated Net Worth of William F Feehery is at least $68.6 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $35,387,994 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.The estimated Net Worth of William F Feehery is at least $75.5 million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $42,281,189 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara. virgin glaactickrystal biotechsolid state batteries company Total cost of revenue for the third quarter of 2023 was $35.9 million, an increase of $3.1 million from $32.8 million in the third quarter of 2022, primarily due to a $3.0 million increase in ...